AGP Executive Report
Last update: 5 hours agoBiotech Regulation: NewAmsterdam Pharma and Menarini won a positive CHMP opinion for Europe marketing authorization of Ubeslo® (obicetrapib) and Evlarco® (obicetrapib + ezetimibe), with an EU Commission decision expected in 2H26, based on Phase 3 BROADWAY, BROOKLYN and TANDEM data. Medtech Finance: Healthcare Holding Schweiz closed a CHF 80m syndicated financing, with Liechtensteinische Landesbank in the syndicate, to fund more acquisitions and shared tech platforms. Fintech & Crypto (Liechtenstein link): Paymonade received a MiCA licence from Liechtenstein’s FMA, enabling regulated crypto-asset services across the EEA under one passportable authorization. Banking Tech: BancaStato launched regulated crypto trading via Sygnum and Avaloq, letting clients trade Bitcoin, Ethereum, Litecoin and Solana inside existing banking apps. Climate Policy: The EU is set to overhaul the Emissions Trading System, including longer free allowances and slower tightening of limits, while linking support to clean-tech investment. Travel Tech & Borders: The EU’s Entry/Exit System (EES) is driving longer airport queues, and UK airports are expanding eGates to children aged 8+ at select sites.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
